Opinion: STAT+: Sanofi CEO Paul Hudson: The right way to bring AI into pharma
STAT
SEPTEMBER 8, 2023
While it’s widely accepted that the pharma industry is innovative in R&D, it is also true that it can be slow at embracing technological revolutions. Many people have criticized pharma companies for being slow to adopt AI. Indeed, some CEOs I talk to are concerned about too widely adopting AI, citing fears of unknown threats. But as the CEO of Sanofi, I don’t believe those challenges should guide our thinking or adoption of AI in the pharma business, as AI has the potential to
Let's personalize your content